Delphine Allorge

4.7k total citations
199 papers, 3.2k citations indexed

About

Delphine Allorge is a scholar working on Toxicology, Pharmacology and Molecular Biology. According to data from OpenAlex, Delphine Allorge has authored 199 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Toxicology, 39 papers in Pharmacology and 28 papers in Molecular Biology. Recurrent topics in Delphine Allorge's work include Forensic Toxicology and Drug Analysis (63 papers), Pharmacogenetics and Drug Metabolism (34 papers) and Psychedelics and Drug Studies (25 papers). Delphine Allorge is often cited by papers focused on Forensic Toxicology and Drug Analysis (63 papers), Pharmacogenetics and Drug Metabolism (34 papers) and Psychedelics and Drug Studies (25 papers). Delphine Allorge collaborates with scholars based in France, Belgium and United Kingdom. Delphine Allorge's co-authors include Jean‐Marc Lo‐Guidice, Franck Broly, Jean‐Michel Gaulier, Camille Richeval, Christelle Cauffiez, Anne Garat, Benjamin Hennart, Michel Lhermitte, Dany Chevalier and Nicolas Beauval and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Delphine Allorge

182 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Delphine Allorge France 33 748 503 482 427 347 199 3.2k
Roberto Russo Italy 44 1.9k 2.5× 268 0.5× 260 0.5× 1.5k 3.6× 217 0.6× 145 6.5k
Jean‐Claude Alvarez France 32 452 0.6× 154 0.3× 482 1.0× 188 0.4× 176 0.5× 215 3.4k
Douglas E. Rollins United States 35 476 0.6× 825 1.6× 818 1.7× 263 0.6× 354 1.0× 113 3.4k
Michael Shannon United States 25 316 0.4× 253 0.5× 270 0.6× 239 0.6× 326 0.9× 70 3.0k
James G. Flood United States 27 365 0.5× 138 0.3× 270 0.6× 260 0.6× 190 0.5× 73 2.5k
Mark M. Kushnir United States 35 1.0k 1.4× 203 0.4× 124 0.3× 257 0.6× 204 0.6× 96 4.0k
Mohsen Azimi–Nezhad Iran 30 662 0.9× 163 0.3× 75 0.2× 390 0.9× 149 0.4× 91 2.8k
Neal L. Benowitz United States 29 1.5k 2.1× 296 0.6× 133 0.3× 2.2k 5.2× 296 0.9× 54 4.5k
Anders Helander Sweden 52 2.0k 2.6× 364 0.7× 2.6k 5.4× 468 1.1× 319 0.9× 226 7.7k
Marta Maria Medeiros Frescura Duarte Brazil 37 828 1.1× 145 0.3× 93 0.2× 476 1.1× 158 0.5× 159 3.7k

Countries citing papers authored by Delphine Allorge

Since Specialization
Citations

This map shows the geographic impact of Delphine Allorge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delphine Allorge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delphine Allorge more than expected).

Fields of papers citing papers by Delphine Allorge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delphine Allorge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delphine Allorge. The network helps show where Delphine Allorge may publish in the future.

Co-authorship network of co-authors of Delphine Allorge

This figure shows the co-authorship network connecting the top 25 collaborators of Delphine Allorge. A scholar is included among the top collaborators of Delphine Allorge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delphine Allorge. Delphine Allorge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Girard, Hugo, Jean‐François Wiart, Luc Humbert, et al.. (2025). Main results of the IN CADAVER protocol: The value of using dried blood spots (DBS) in post-mortem forensic toxicology. Annales de Toxicologie Analytique. 37(1). S23–S23.
2.
Beauval, Nicolas, et al.. (2024). Assessment of chemical contamination by cancer drugs during use of the RIVA TM compounding robot: A pilot study. Journal of Oncology Pharmacy Practice. 31(7). 1061–1070.
3.
Humbert, Luc, et al.. (2023). La chromatographie en phase supercritique (SFC) ultrarapide (Fast SFC) : un outil complémentaire au service de l’analyste. Annales de Toxicologie Analytique. 35(3). 217–224.
4.
Richeval, Camille, et al.. (2023). Un panorama actuel de la nature de « La Chimique » consommée à Mayotte : résultats préliminaires de CHASSE-MARÉE. Annales de Toxicologie Analytique. 35(2). S32–S32. 2 indexed citations
5.
Gaulier, Jean‐Michel, Hugo Girard, Camille Richeval, et al.. (2023). Étude pilote du projet IN CADAVER : preuve de concept d’une voie future de la toxicologie post-mortem (et nouveau paradigme ?). Annales de Toxicologie Analytique. 35(2). S25–S25. 1 indexed citations
6.
Beauval, Nicolas, et al.. (2023). Lead, Mercury, and Cadmium Concentrations in Blood Products Transfused to Neonates: Elimination Not Just Mitigation. Toxics. 11(8). 712–712. 3 indexed citations
7.
Richeval, Camille, et al.. (2023). The potential of keratinized matrices for the retrospective exploration of repeated ayahuasca use by patients. Clinical Toxicology. 61(11). 1010–1011. 2 indexed citations
10.
Allorge, Delphine, et al.. (2023). Four-year follow-up of surface contamination by antineoplastic drugs in a compounding unit. Occupational and Environmental Medicine. 80(3). 146–153. 6 indexed citations
11.
Ducloy‐Bouthors, A.‐S., et al.. (2022). Pharmacokinetics of Curative Tranexamic Acid in Parturients Undergoing Cesarean Delivery. Pharmaceutics. 14(3). 578–578. 7 indexed citations
12.
Fabresse, Nicolas, Alice Ameline, Pascal Kintz, et al.. (2022). Pregabalin misuse: About seven cases of death in the region of Marseille. SPIRE - Sciences Po Institutional REpository.
13.
Nisse, Patrick, et al.. (2022). Aldicarb-related suicide attempt cases in North of France (2012–2021). Toxicology Research. 11(3). 529–536. 4 indexed citations
14.
Onimus, Thierry, Arthur Durand, Julien Goutay, et al.. (2021). Intoxication sévère par cardiotropes avec suivi en temps réel des concentrations sanguines. Annales de Toxicologie Analytique. 33(2). 147–152.
15.
Gholam‐Rezaee, Mehdi, Benjamin Hennart, Marc Augsburger, et al.. (2021). Metabolomic alteration induced by psychotropic drugs: Short‐term metabolite profile as a predictor of weight gain evolution. Clinical and Translational Science. 14(6). 2544–2555. 3 indexed citations
16.
Meireson, Annabel, Simon J. Tavernier, Sofie Van Gassen, et al.. (2021). Immune Monitoring in Melanoma and Urothelial Cancer Patients Treated with Anti-PD-1 Immunotherapy and SBRT Discloses Tumor Specific Immune Signatures. Cancers. 13(11). 2630–2630. 4 indexed citations
17.
Simon, Nicolas, Camille Richeval, Marion Soichot, et al.. (2018). A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study. PLoS ONE. 13(8). e0201335–e0201335. 9 indexed citations
18.
Hennart, Benjamin, Robert Caïazzo, Audrey Leloire, et al.. (2015). The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation. Obesity. 23(10). 2066–2074. 208 indexed citations
19.
Allorge, Delphine, et al.. (2015). SUBACUTE TOXICOLOGICAL EFFECTS OF EMAMECTINE BENZOATE ON WISTAR RAT TESTES: HISTOPATHOLOGICAL CHANGES, DETERMINATION OF EMAMECTIN BENZOATE RESIDUES BY UPLC-MS/MS AND PROTECTIVE EFFECT OF VITAMIN C. 3(1). 365–374. 2 indexed citations
20.
Cauffiez, Christelle, Delphine Allorge, Jean‐Marc Lo‐Guidice, et al.. (2001). Five novel natural allelic variants?951A>C, 1042G>A (D348N), 1156A>T (I386F), 1217G>A (C406Y) and 1291C>T (C431Y)?of the human CYP1A2 gene in a French Caucasian population. Human Mutation. 17(4). 355–356. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026